Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

795
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
795
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

256
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
256
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

351
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
351
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

308
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
308
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

293
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer's disease.

Expert review of clinical pharmacology·2025
Same author

An Age-Friendly Approach to Medication Optimization.

The Senior care pharmacist·2025
Same author

Lunar dust induces minimal pulmonary toxicity compared to Earth dust.

Life sciences in space research·2025
Same author

Expanding vaccination access in underserved communities across Maryland through a collaborative approach.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

The mechanosensitive channel ELKIN1 regulates cellular adaptations to simulated microgravity.

NPJ microgravity·2025

Related Experiment Video

Updated: Jan 30, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.2K

Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.

Joshua Chou, Monica Tong, Nicole J Brandt

    Journal of Gerontological Nursing
    |January 18, 2019
    PubMed
    Summary

    Polypharmacy, the use of five or more medications, is common in older adults. Deprescribing, guided by tools like the Beers Criteria, helps manage risks such as side effects and drug interactions.

    More Related Videos

    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
    10:43

    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices

    Published on: November 5, 2016

    9.5K
    Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
    11:29

    Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

    Published on: August 15, 2025

    2.3K

    Related Experiment Videos

    Last Updated: Jan 30, 2026

    A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
    06:59

    A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

    Published on: November 9, 2016

    31.2K
    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
    10:43

    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices

    Published on: November 5, 2016

    9.5K
    Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
    11:29

    Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

    Published on: August 15, 2025

    2.3K

    Area of Science:

    • Gerontology
    • Pharmacology
    • Public Health

    Background:

    • Polypharmacy, defined as using five or more medications, is a growing concern among older adults in the U.S.
    • The risks of polypharmacy include adverse drug events, drug interactions, and reduced quality of life.
    • Effective management strategies are needed to address this prevalent issue in geriatric care.

    Purpose of the Study:

    • To highlight the increasing prevalence of polypharmacy in older adults.
    • To discuss the role of deprescribing as a strategy to mitigate polypharmacy-related risks.
    • To emphasize the utility of existing guidelines, such as the American Geriatrics Society Beers Criteria, in clinical practice.

    Main Methods:

    • Review of current literature and clinical guidelines on polypharmacy and deprescribing.
    • Analysis of the framework and tools available for healthcare providers to address polypharmacy.
    • Discussion of practical approaches for implementing deprescribing in geriatric populations.

    Main Results:

    • Polypharmacy is a significant and increasing issue in the elderly population.
    • Deprescribing, supported by established criteria, offers a structured approach to medication review.
    • Tools like the Beers Criteria are essential for identifying and managing inappropriate medication use.

    Conclusions:

    • Deprescribing is a valuable framework for healthcare providers to manage polypharmacy in older adults.
    • Utilizing existing guidelines and resources is crucial for safe and effective medication reduction.
    • Addressing polypharmacy through deprescribing can improve patient outcomes and reduce healthcare burdens.